Vaccinia virus WR gene A5L is required for morphogenesis of mature virions

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 4590-4599

  Williams, Ollie ^a   Wolffe, Elizabeth J ^b   Weisberg, Andrea S ^b   Merchlinsky, Michael ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; GENE DELETION; GENE EXPRESSION SYSTEM; GENE INDUCTION; MORPHOGENESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; VACCINIA VIRUS; VIRION; VIRUS GENE; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 0033035414     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.4590-4599.1999     Document Type: Article

References (58)

1. Alexander, W. A., B. Moss, and T. R. Fuerst 1992. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor. J. Virol. 66:2934-2942.
2. Antoine, G., F. Scheiflinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia ankara strain: comparison with other orthopoxviruses. Virology 244:365-396.
3. Blasco, R., and B. Moss. 1991. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65:5910-5920.
4. Cairns, J. 1960. The initiation of vaccinia infection. Virology 11:603-623.
5. Cassetti, M. C., M. Merchlinsky, E. J. Wolffe, A. S. Weisberg, and B. Moss. 1998. DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles. J. Virol. 72:5769-5780.
6. Cudmore, S., R. Blasco, R. Vincentelli, M. Esteban, B. Sodeik, G. Griffiths, and J. K. Locker. 1996. A vaccinia virus core protein, p39, is membrane associated. J. Virol. 70:6909-6921.
7. Dales, S., and L. Siminovitch. 1961. The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy. J. Biophys. Biochem. Cytol. 10:475-498.
8. Demkowicz, W. E., J.-S. Maa, and M. Esteban. 1992. Identification and characterization of vaccinia genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J. Virol. 66:386-398.
9. Duncan, S. A., and G. L. Smith. 1992. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 66:1610-1621.
10. Earl, F. L., N. Cooper, and B. Moss. 1991. Preparation of cell cultures and vaccinia virus stocks, p. 16.16.1-16.16.7. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
11. Earl, P. L., and B. Moss. 1991. Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.16. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
12. Engelstad, M., and G. L. Smith. 1993. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194:627-637.
13. Ericsson, M., S. Cudmore, S. Shuman, R. C. Condit, G. Griffiths, and J. K. Locker. 1995. Characterization of ts16, a temperature-sensitive mutant of vaccinia virus. J. Virol. 69:7072-7086.
14. Fuerst, T. R., M. P. Fernandez, and B. Moss. 1989. Transfer of the inducible lac represser/operator system from Escherichia coli to a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:2549-2553.
15. Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266.
16. Grimley, P. M., E. N. Rosenblum, S. J. Mims, and B. Moss. 1970. Interruption by rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J. Virol. 6:519-533.
17. Gross, C. H., and S. Shuman. 1996. Vaccinia virions lacking the RNA helicase nucleoside triphosphate phosphohydrolase II are defective in early transcription. J. Virol. 70:8549-8557.
18. Harford, C. G., A. Hamlin, and E. Riders. 1966. Electron microscopic autoradiography of DNA synthesis in cells infected with vaccinia virus. Exp. Cell Res. 42:50-57.
19. Hu, X., L. J. Carroll, E. J. Wolffe, and B. Moss. 1996. De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions. J. Virol. 70:7669-7677.
20. Hu, X., E. J. Wolffe, A. S. Weisberg, L. J. Carroll, and B. Moss. 1998. Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virions. J. Virol. 72: 104-112.
21. Joklik, W. K., and Y. Becker. 1964. The replication and coating of vaccinia DNA. J. Mol. Biol. 10:452-474.
22. Kane, E. M., and S. Shuman. 1993. Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J. Virol. 67:2689-2698.
23. Kates, J. R., and B. R. McAuslan. 1967. Poxvirus DNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA 58:134-141.
24. Katz, E., and B. Moss. 1970. Formation of a vaccinia virus structural polypeptide from a high molecular weight precursor: inhibition by rifampicin. Proc. Natl. Acad. Sci. USA 66:677-684.
25. Katz, E., and B. Moss. 1970. Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles. J. Virol. 6:717-726.
26. Lakritz, N., P. D. Foglesong, M. Reddy, S. Baum, J. Hurwitz, and W. R. Bauer. 1985. A vaccinia DNase preparation which cross-links superhelical DNA. J. Virol. 53:935-943.
27. r, immunodominant protein of vaccinia virus. J. Virol. 61:3910-3919.
28. Merchlinsky, M., C. F. Garon, and B. Moss. 1988. Molecular cloning and sequence of the concatemer junction from vaccinia virus replicative DNA. Viral nuclease cleavage sites in cruciform structures. J. Mol. Biol. 199:399-413.
29. Merchlinsky, M., and B. Moss. 1989. Resolution of vaccinia virus DNA concatemer junctions requires late gene expression. J. Virol. 63:1595-1603.
30. Merchlinsky, M. Unpublished results.
31. Moss, B. 1996. Poxviridae: the viruses and their replication, p. 2637-2672. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
32. Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. New mammalian expression vectors. Nature (London) 348:91.
33. Moss, B., and E. N. Rosenblum. 1973. Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin. J. Mol. Biol. 81:267-269.
34. Munyon, W. E., E. Paoletti, and J. T. Grace, Jr. 1967. RNA polymerase activity in purified infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 58:2280-2288.
35. r, 43-50 K protein on the surface of extracellular enveloped virus. Virology 204:376-390.
36. Ravanello, M. P., and D. E. Hruby. 1994. Conditional lethal expression of the vaccinia virus L1R myristylated protein reveals a role in virion assembly. J. Virol. 68:6401-6410.
37. Rodriguez, D., M. Esteban, and J. R. Rodriguez. 1995. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J. Virol. 69:4640-4648.
38. Rodriguez, D., C. Risco, J. R. Rodriguez, and M. Esteban. 1996. Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J. Virol. 70:7641-7653.
39. Rodriguez, J. F., and G. L. Smith. 1990. IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res. 18:5347-5351.
40. Roper, R. L., L. G. Payne, and B. Moss. 1996. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70:3753-3762.
41. Rosemond-Hornbeak, H., and B. Moss. 1974. Single-strand deoxyribonucleic acid-specific nuclease from vaccinia virus. Endonucleolytic and exonucleolytic activities. J. Biol. Chem. 249:3292-3296.
42. Rosemond-Hornbeak, H., E. Paoletti, and B. Moss. 1974. Single-strand deoxyribonucleic acid-specific nuclease from vaccinia virus. Purification and characterization. J. Biol. Chem. 249:3287-3291.
43. r protein confers resistance to an inhibitor of virus envelopment and release. J. Virol. 65:3435-3442.
44. Senkevich, T. G., J. J. Bugert, J. R. Sisler, E. V. Koonin, G. Darai, and B. Moss. 1996. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 273:813-816.
45. Silver, M., and S. Dales. 1982. Biogenesis of vaccinia: interrelationship between posttranslational cleavage, virus assembly, and maturation. Virology 117:341-356.
46. Sutter, G., and B. Moss. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89:10847-10851.
47. Tartaglia, J., and E. Paoletti. 1985. Physical mapping and DNA sequence analysis of the rifampin resistance locus in vaccinia virus. Virology 147:394-404.
48. Traktman, P., A. Caligiuri, S. A. Jesty, K. Liu, and K. Sankar. 1995. Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J. Virol. 69: 6581-6587.
49. VanSlyke, J. K., C. A. Franke, and D. E. Hruby. 1991. Proteolytic maturation of vaccinia virus core proteins: identification of a conserved motif at the N termini of the 4b and 25K virion proteins. J. Gen. Virol. 72:411-416.
50. VanSlyke, J. K., P. Lee, E. M. Wilson, and D. E. Hruby. 1993. Isolation and analysis of vaccinia virus previrions. Virus Genes 7:311-324.
51. VanSlyke, J. K., S. S. Whitehead, E. M. Wilson, and D. E. Hruby. 1991. The multistep proteolytic maturation pathway utilized by vaccinia virus p4a protein: a degenerate conserved cleavage motif within core proteins. Virology 183:467-478.
52. Wang, S., and S. Shuman. 1995. Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J. Virol. 69:6376-6388.
53. Ward, G. A., C. K. Stover, B. Moss, and T. R. Fuerst. 1995. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc. Natl. Acad. Sci. USA 92:6773-6777.
54. Wolffe, E. J., S. N. Isaacs, and B. Moss. 1993. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67:4732-4741.
55. Wolffe, E. J., D. M. Moore, P. J. Peters, and B. Moss. 1996. Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J. Virol. 70:2797-2808.
56. Zhang, Y., and B. Moss. 1992. Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin. Virology 187:643-653.
57. Zhang, Y., and B. Moss. 1991. Inducer-dependent conditional-lethal mutant animal viruses. Proc. Natl. Acad. Sci. USA 88:1511-1515.
58. Zhang, Y., and B. Moss. 1991. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor. J. Virol. 65:6101-6110.